SCHEMBL6318500

SCHEMBL6318500

CN(C)CC(=O)NCc1ccc(NC(=C2C(=O)Nc3ccc([N+](=O)[O-])cc32)c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.41
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
MAPT P10636 3/20 0.38
KDM4E B2RXH2 1/20 0.38
AKT2 P31751 2/20 0.37
CAPN9 O14815 1/20 0.37
CASP3 P42574 1/20 0.37
PDPK1 O15530 1/20 0.37
TGM2 P21980 1/20 0.37
THRA P10827 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318492 1.00 EGFR (0.41) EGFRALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL6320201 0.92 ALDH1A1 (0.41) EGFRALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL6322835 0.92 ALDH1A1 (0.41) EGFRALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL6320361 0.92 EGFR (0.44) EGFRALDH1A1HTTMEN1KMT2A
SCHEMBL6320358 0.92 EGFR (0.44) EGFRALDH1A1HTTMEN1KMT2A
SCHEMBL6328248 0.89 PDPK1 (0.45) EGFRALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6328256 0.89 PDPK1 (0.45) EGFRALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6404857 0.89 EGFR (0.36) EGFRALDH1A1SMN1; SMN2LMNAHPGD
Hydrochloric Acid SCHEMBL6324886 0.89 EGFR (0.41) EGFRALDH1A1SMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL6326914 0.88 AKT2 (0.45) EGFRALDH1A1SMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6855710-B2 Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-02-15 US disclosed
EP-1115704-B1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-06-18 EP disclosed